Detalhe da pesquisa
1.
Distinct gut microbiota signatures associated with progression of atherosclerosis in people living with HIV.
J Infect Dis
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38743815
2.
T-Cell Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Measured by an Interferon-γ Release Assay Is Strongly Associated With Patient Outcomes in Vaccinated Persons Hospitalized With Delta or Omicron Variants.
J Infect Dis
; 228(9): 1240-1252, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37418551
3.
Human Immunodeficiency Virus Type 1 RNA Levels in Rectal and Seminal Compartments After Switching to Long-Acting Cabotegravir Plus Rilpivirine: A Longitudinal Study.
Clin Infect Dis
; 76(3): e748-e751, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35986671
4.
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial.
Clin Infect Dis
; 76(5): 861-870, 2023 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36259527
5.
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial.
Clin Infect Dis
; 77(7): 991-1009, 2023 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207617
6.
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression.
N Engl J Med
; 382(12): 1112-1123, 2020 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32130809
7.
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.
J Antimicrob Chemother
; 78(9): 2361-2365, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37539492
8.
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.
J Antimicrob Chemother
; 78(11): 2696-2701, 2023 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725999
9.
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021.
J Med Virol
; 95(12): e29287, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38084763
10.
Systematic screening of gender violence and domestic violence among HIV-positive patients: the VIHOLETA study.
AIDS Care
; 35(10): 1443-1451, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36169405
11.
Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses.
BMC Infect Dis
; 23(1): 286, 2023 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142994
12.
Clinical Performance of a Standardized Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Interferon-γ Release Assay for Simple Detection of T-Cell Responses After Infection or Vaccination.
Clin Infect Dis
; 75(1): e338-e346, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34893816
13.
Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy.
Clin Infect Dis
; 75(8): 1324-1333, 2022 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35235653
14.
Survival benefit of remdesivir in hospitalized COVID-19 patients with high SARS-CoV-2 viral loads and low-grade systemic inflammation.
J Antimicrob Chemother
; 77(8): 2257-2264, 2022 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35534369
15.
Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study.
J Antimicrob Chemother
; 77(7): 1980-1988, 2022 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35411401
16.
Pericarditis caused by Mycobacterium africanum: case report.
BMC Infect Dis
; 22(1): 628, 2022 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35850703
17.
Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study.
J Clin Immunol
; 41(7): 1490-1501, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34273064
18.
Performance of Saliva Specimens for the Molecular Detection of SARS-CoV-2 in the Community Setting: Does Sample Collection Method Matter?
J Clin Microbiol
; 59(4)2021 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33419948
19.
Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV.
J Antimicrob Chemother
; 76(9): 2380-2393, 2021 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34120186
20.
Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study.
J Autoimmun
; 123: 102703, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34303083